4 withdrawn. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Streptococcal Infections: new trials by email Literature Review of Streptococcal Infections trials Research Report on Streptococcal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GBS-NN/NN2 (50 µg of Each Fusion Protein [GBS-NN and GBS-NN2] in Combination With 500 µg Aluminum as Alhydrogel®) Given With and Without the Tdap Vaccine in Healthy Non-pregnant Women 18 to 49 Years of Age GBS-NN/NN2 vaccine, Tdap vaccine, Placebo - Streptococcus Agalactiae Infection | Phase 2 / Phase 3 | Withdrawn | Minervax ApS | 2024-12-17 | 2026-10-13 | |
| The Use of Oral Steroids in the Treatment of Cellulitis Prednisone, Placebo Oral Tablet - Cellulitis, Erysipelas | Phase 2 | Withdrawn | Milton S. Hershey Medical Center | 2010-01-15 | 2017-07-25 | |
| Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure Inhaled Prostaglandin E1 - Infant, Newborn, Respiratory Insufficiency | Phase 2 | Withdrawn | NICHD Neonatal Research Network | 2008-05-01 | 2019-03-22 | |
| Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women PPV-23 Vaccine, PCV-13 Vaccine, Placebo Vaccine - Pneumococcal Infections, HIV Infections | Phase 2 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-11-01 |
Cellulitis (1) · Erysipelas (1) · HIV Infections (1) · Hypertension, Pulmonary (1) · Meconium Aspiration Syndrome (1) · Persistent Fetal Circulation Syndrome (1) · Pneumococcal Infections (1) · Respiratory Distress Syndrome, Newborn (1) · Respiratory Insufficiency (1)
Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Gram-Positive Bacterial Infections (4) · Infections (4) · Urogenital Diseases (2) · Blood-Borne Infections (1) · Cardiovascular Diseases (1) · Communicable Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Fetal Diseases (1) · Genital Diseases (1) · Hypertension (1)
13-valent pneumococcal vaccine (1) · Alprostadil (1) · Boostrix (1) · Prednisone (1)
Milton S. Hershey Medical Center (1) · Minervax ApS (1) · NICHD Neonatal Research Network (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (1)
Adriana Weinberg, MD (1) · Edward F. Bell, MD (1) · Krisa P. Van Meurs, MD (1) · Kristi L. Watterberg, MD (1) · Michele C. Walsh, MD MS (1) · Pablo J. Sanchez, MD (1) · Roger G. Faix, MD (1) · Ronald N. Goldberg, MD (1) · Scott Goldstein, DO (1) · Seetha Shankaran, MD (1) · Waldemar A. Carlo, MD (1)
2023 (1), U10HD021364 (1), U10HD021385 (1), U10HD027880 (1), U10HD034216 (1), U10HD036790 (1), U10HD040492 (1), U10HD040689 (1), U10HD053089 (1), U10HD053109 (1), U10HD053119 (1), U10HD053124 (1)